ProLectin-M Demonstrates Significant Activity Against Influenza and Respiratory Syncytial Virus
28. Februar 2023 08:00 ET
|
BIOXYTRAN, INC.
Activity in Influenza and Respiratory Syncytial Virus highlights the broad- spectrum antiviral potential of ProLectin-M BOSTON, MASSACHUSETTS, Feb. 28, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC....